NEW YORK (GenomeWeb) – Between rapid diagnoses of critically ill infants and unwieldy general population screening tests, four National Institutes of Health-funded projects are illustrating both the promise and challenges of sequencing the genomes of newborns.

At Cambridge Healthtech Institute's Molecular Medicine Tri-Conference in San Francisco last month, researchers from the four Newborn Sequencing in Genomic Medicine and Public Health (NISGHT) study sites described progress their institutions have made, challenges, and future plans.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.